Online Webinars

Previous Webinars

Jan 22, 2019

From Biomarkers to Companion Diagnostics:

In immuno-oncology, companion diagnostics are used in conjunction with targeted drugs and therapies to identify patients who are likely to benefit from a specific treatment regimen or who may have increased risk for certain side effects. Join this webinar for a discussion of the integration of digital pathology, clinical trial design and tissue-based...
View Full Event Post
Oct 9, 2018

Identifying Spatial Expression Patterns in the Tumor Microenvironment

Summary: In this webinar, Dr. Rognoni describes the development of an automated workflow for quantitative analysis of multispectral immunofluorescence whole-tissue scans. This technique, developed at Definiens, allows the identification of spatial patterns for immunoprofiling, overcoming the limitation of small regions of interests and providing significant amount of data on the...
View Full Event Post
Sep 12, 2018

Tissue-based profiling for confident decisions in immuno-oncology

Summary This webcast highlights the benefits of standardizing tissue profiling for decision making in drug development and trial designs in immuno-oncology. Key topics include: Challenges in comparing results across different clinical studies that result from inconsistent biomarker strategies are discussed A harmonized tissue profiling strategy is introduced as a promising...
View Full Event Post
Jul 26, 2018

Deep Learning: Automated PD-L1 Tumor Cell Scoring of Resected NSCLC

PD-L1 expression measured by immunohistochemistry helps identify non-small cell lung cancer (NSCLC) patients that may respond to anti-PD-1/PD-L1 immunotherapies. In this webinar, our featured speaker will present a novel deep learning solution for the automated scoring of PD-L1+ tumor cells (TC) in whole slide images of resected NSCLC. A convolutional...
View Full Event Post
Nov 21, 2017

Multiplex IHC Immuno-Oncology Panel

Characterization of the immune status of patients becomes increasingly important to personalize cancer treatments. The required extraction of information and biological insights from tissue slides remains challenging because of the broad heterogeneity of tumor and immune cells embedded in the complex tumor microenvironment. Thus, the analysis requires expert insights as...
View Full Event Post